Nebula Research & Development LLC Harmony Biosciences Holdings, Inc. Transaction History
Nebula Research & Development LLC
- $852 Billion
- Q4 2024
A detailed history of Nebula Research & Development LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 18,560 shares of HRMY stock, worth $549,561. This represents 0.07% of its overall portfolio holdings.
Number of Shares
18,560Holding current value
$549,561% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
262Shares Held
47MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$196 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$173 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$140 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$67.5 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$46.8 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.75B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...